NIAID-Funded Adjuvant Improves Typhoid Vaccine Candidate in Animal Studies

An investigational typhoid vaccine containing a component developed with NIAID funding may overcome some of the shortcomings of available typhoid vaccines, according to a paper published in the journal Vaccine in June.

Accelerating Next-Generation Vaccine Development for Global

Global Innovations (International Cooperation

Controlled Human Infection Models To Accelerate Vaccine

Transcriptional correlates of malaria in RTS,S/AS01-vaccinated

World experts to gather for IVI symposium on hepatitis E – IVI

Emerging concepts in the science of vaccine adjuvants

niaid intramural contributions, 1887-1987 - Office of NIH History

Frontiers Polyphosphazenes as Adjuvants for Animal Vaccines and

Malaria transmission-blocking conjugate vaccine in ALFQ adjuvant

Intestinal helminth infection impairs oral and parenteral vaccine